Atlas Trials

OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder

Clinical trial NCT04948307 · COMPLETED

Trial details

NCT number
NCT04948307
Sponsor
Orexo AB
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Opioid-use Disorder
Start date
2021-06-30
Primary completion
2023-04-12
Enrollment
437

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.